Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 2 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready
Coherent Biopharma (Suzhou) Limited has 3 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 3 distinct examiners across 2 distinct art units, indicating examiner diversity with some shared technical assignment.
SABILA, MERCY HELLEN is the busiest examiner, with 1 pending matter. Counsel can coordinate matters within the art-unit structure while preserving separate strategies for each examiner.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 3 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SABILA, MERCY HELLEN | 1 | 57.5% | +45.3% |
| PIHONAK, SARAH | 1 | 61.4% | +42.4% |
| HELLMAN, KRISTINA M | 1 | 65.1% | +55.5% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18703208 | CONJUGATE PHARMACEUTICAL PREPARATION, PREPARATION METHOD THEREFOR AND USE THEREOF | SABILA, MERCY HELLEN | — |
| 18690561 | PHARMACEUTICAL PREPARATION, PREPARATION METHOD THEREFOR AND USE THEREOF | PIHONAK, SARAH | — |
| 18573083 | LIGAND-DRUG CONJUGATE AND USE THEREOF | HELLMAN, KRISTINA M | — |
| Art Unit | Apps |
|---|---|
| 1654 | 2 |
| 1627 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18703208 | CONJUGATE PHARMACEUTICAL PREPARATION, PREPARATION METHOD THEREFOR AND USE THEREOF | SABILA, MERCY HELLEN | 1654 | §102§112DP | Non-Final OA | — | Pending | Apr 19, 2024 |
| 18690561 | PHARMACEUTICAL PREPARATION, PREPARATION METHOD THEREFOR AND USE THEREOF | PIHONAK, SARAH | 1627 | §103§112DP | Non-Final OA | — | Pending | Mar 08, 2024 |
| 18573083 | LIGAND-DRUG CONJUGATE AND USE THEREOF | HELLMAN, KRISTINA M | 1654 | §102§112DP | Non-Final OA | — | Pending | Dec 21, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialCoherent Biopharma (Suzhou) Limited has 3 pending office actions as of October 2026, spread across 2 art units and 3 examiners.
Mercy Hellen Sabila has the most, with 1 of Coherent Biopharma (Suzhou) Limited's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
